Sorafenib Therapy Is Associated with Improved Outcomes for FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Sorafenib Therapy Is Associated with Improved Outcomes for FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

Published:2019-08 Issue:8 Volume:25 Page:1674-1681
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Xuan Li,Wang Yu,Chen Jia,Jiang Erlie,Gao Li,Wu Bingyi,Deng Lan,Liang Xinquan,Huang Fen,Fan Zhiping,Tang Xiaowen,Sun Jing,Zhang Xi,Han Mingzhe,Wu Depei,Huang Xiaojun,Liu Qifa

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference37 articles.

1. Genomic classification and prognosis in acute myeloid leukemia;Papaemmanuil;N Engl J Med,2016

2. Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution;DeZern;Biol Blood Marrow Transplant,2011

3. Hematopoietic transplantation for acute myeloid leukemia with internal tandem duplication of FLT3 gene (FLT3/ITD);Brunet;Curr Opin Oncol,2013

4. Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers;Sengsayadeth;Bone Marrow Transplant,2012

5. The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology;Xu;J Hematol Oncol,2018

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prévention de la rechute des leucémies aiguës et syndromes myélodysplasiques en post-allogreffe : stratégies prophylactique et préemptive (SFGM-TC);Bulletin du Cancer;2024-09

2. Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3‐ITD: A multicenter phase 2 study;Journal of Internal Medicine;2023-10-29

3. Novel Approaches to Treatment of Acute Myeloid Leukemia Relapse Post Allogeneic Stem Cell Transplantation;International Journal of Molecular Sciences;2023-10-09

4. Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study;Signal Transduction and Targeted Therapy;2023-09-14

5. Donor lymphocyte infusion in Acute Myeloid Leukemia;Best Practice & Research Clinical Haematology;2023-09